Showing results (71-80 of 282) with videos related to
Sort By:
Pageof 29
Cancer|October 23, 2014
Results of phase 2 randomized study of low-dose decitabine with or without valproic acid in patients with myelodysplastic syndrome and acute myelogenous leukemiaJean-Pierre Issa, Guillermo Garcia-Manero, Xuelin Huang, et al.Cancer|October 22, 2008
Treatment of core-binding-factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event-free survivalGautam Borthakur, Hagop Kantarjian, Xuemei Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia veraAlfonso Quintás-Cardama, Hagop Kantarjian, Taghi Manshouri, et al.Blood|February 15, 2003
Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemiaLanLan Shen, Minoru Toyota, Yutaka Kondo, et al.Leukemia Research|June 28, 2005
Aberrant DNA methylation of a cell cycle regulatory pathway composed of P73, P15 and P57KIP2 is a rare event in children with acute lymphocytic leukemiaAndreia A Canalli, Hui Yang, Sima Jeha, et al.Cancer|October 2, 2009
Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome and chromosome 5 and 7 abnormalitiesFarhad Ravandi, Jean-Pierre Issa, Guillermo Garcia-Manero, et al.Genes, Chromosomes & Cancer|November 13, 2009
Modeling interactions between leukemia-specific chromosomal changes, somatic mutations, and gene expression patterns during progression of core-binding factor leukemiasDan Jones, Hui Yao, Angela Romans, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
Association of comorbidities with overall survival in myelodysplastic syndrome: development of a prognostic modelKiran Naqvi, Guillermo Garcia-Manero, Sagar Sardesai, et al.Blood|January 10, 2009
The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease courseConstantine S Tam, Lynne V Abruzzo, Katherine I Lin, et al.Cancer|May 10, 2012
Clinical and proteomic characterization of acute myeloid leukemia with mutated RASTapan M Kadia, Hagop Kantarjian, Steven Kornblau, et al.Pageof 29